Characteristics of methamphetamine-related deaths in the United Kingdom, 1997-2024

Emmert Roberts1,2, Rebecca McKetin2, Caroline Copeland3

  • 1National Addiction Centre, King's College London, London, UK.

PubMed
Abstract

Insights

Methamphetamine-related deaths in the UK have increased over two decades, primarily affecting males with substance dependence and mental health issues. Polysubstance use was common in these fatalities.

Area of Science:

  • Public Health
  • Toxicology
  • Epidemiology

Background:

  • Methamphetamine use is associated with significantly higher mortality rates globally.
  • Recent decades show a concerning rise in methamphetamine-related deaths internationally.
  • Limited research exists on methamphetamine mortality trends within the United Kingdom (UK).

Purpose of the Study:

  • To investigate the trends and characteristics of methamphetamine-related deaths in the UK.
  • To analyze sociodemographic factors and co-occurring conditions in decedents.
  • To identify patterns in drug toxicity and causes of death.

Main Methods:

  • A retrospective cohort study design was employed.
  • Data were sourced from the National Programme on Substance Use Mortality (NPSUM) in the UK, spanning 1997-2024.
  • Coronial records of decedents with methamphetamine implicated in their death were analyzed.

Main Results:

  • 136 methamphetamine-related deaths were identified between 1997 and 2024, with a notable increase over time.
  • Decedents were predominantly male (91%), White (50%), with a mean age of 41.5 years.
  • High prevalence of substance dependence (77%), mental health disorders (88%), and polysubstance use (65%) were observed.

Conclusions:

  • Methamphetamine-related fatalities in the UK have increased over the past two decades.
  • These deaths predominantly involve males with pre-existing substance dependence and mental health conditions.
  • Polysubstance use is a significant factor contributing to methamphetamine-related mortality.

Related Concept Videos

Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
674
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
828
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
631